Abstract
In this issue of Blood, Pfreundschuh et al report that young males treated with rituximab-based immunochemotherapy in contrast to elderly males benefit as much as females from rituximab immunochemotherapy and patients with more rapid rituximab clearance have reduced therapeutic benefit.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 602-603 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 123 |
| Issue number | 5 |
| DOIs | |
| State | Published - Jan 30 2014 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology